UK markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
301.28-0.69 (-0.23%)
At close: 03:46PM EDT
Annual

Cash flow

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
5,467,000
4,352,000
5,452,000
2,957,000
4,758,000
Depreciation & amortisation
-
295,000
362,000
248,000
259,000
Stock-based compensation
-
586,000
439,000
310,000
200,000
Change in working capital
-1,076,000
1,362,000
-1,840,000
-705,000
987,000
Inventory
-
-57,000
0
0
-
Other working capital
5,358,000
7,004,000
3,595,000
1,976,000
6,126,000
Other non-cash items
-878,000
-912,000
-303,000
-216,000
-174,000
Net cash provided by operating activities
5,658,000
7,380,000
3,912,000
2,228,000
6,433,000
Cash flows from investing activities
Investments in property, plant and equipment
-300,000
-376,000
-317,000
-252,000
-307,000
Purchases of investments
-12,585,000
-10,907,000
-9,698,000
-15,616,000
-12,414,000
Sales/maturities of investments
10,175,000
10,001,000
7,254,000
14,907,000
10,370,000
Net cash used for investing activities
-2,710,000
-1,282,000
-2,761,000
-961,000
-2,351,000
Cash flows from financing activities
Debt repayment
-94,000
-91,000
-73,000
-58,000
-44,000
Common stock issued
-
-
-
0
0
Common stock repurchased
-566,000
-564,000
-908,000
-447,000
0
Other financing activities
-109,000
-103,000
-88,000
-50,000
-25,000
Net cash used provided by (used for) financing activities
-590,000
-606,000
-789,000
-420,000
71,000
Net change in cash
2,358,000
5,492,000
362,000
847,000
4,153,000
Cash at beginning of period
12,288,000
9,893,000
8,957,000
7,260,000
3,552,000
Cash at end of period
14,646,000
14,867,000
9,893,000
8,957,000
7,260,000
Free cash flow
Operating cash flow
5,658,000
7,380,000
3,912,000
2,228,000
6,433,000
Capital expenditure
-300,000
-376,000
-317,000
-252,000
-307,000
Free cash flow
5,358,000
7,004,000
3,595,000
1,976,000
6,126,000